Mounjaro (tirzepatide) is a GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus
FDA approves new drug treatment for chronic weight management, first since 2014, Food and Drug Administration (2021) FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight, Food and Drug Administration (2024) Wegovy prescribing information, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Understanding these possible links can help you better manage any side effects and continue to benefit from semaglutides positive effects on your health
Consider high-water content foods: Soups, broths, and fruits like watermelon and cucumber can contribute to your fluid intake
Tran CS, Chan CB
However, decongestants like pseudoephedrine, often combined in cold remedies, can raise blood pressure and cause jitteriness, which might be exacerbated if combined improperly
.png)
